The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry

Journal of Cancer Survivorship

Volumn 8, Issue 4, 2014, Pages 555-564

  Oerlemans, Simone ^a,b   Mols, Floortje ^a,b   Nijziel, Marten R ^c   Zijlstra, Wobbe P ^b   Coebergh, Jan Willem W ^d   van de Poll Franse, Lonneke V ^a,b  

^a The Netherlands   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety; Cancer survivors; Depression; Diffuse large B cell lymphoma; Hodgkin lymphoma; Non Hodgkin lymphoma; Population based; Quality of life

Indexed keywords

ADULT; AGED; ANXIETY; B CELL LYMPHOMA; DEPRESSION; FEMALE; HODGKIN DISEASE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY OF LIFE; SURVIVOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; FEMALE; HODGKIN DISEASE; HUMANS; LONGITUDINAL STUDIES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVORS;

EID: 84936753422     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-014-0367-1     Document Type: Article

References (41)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2013, assessed on August 2013. 2013.
2. van de Schans SA, Issa DE, Visser O, et al. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007. Ann Oncol. 2012;23:171–82.
3. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431–9.
4. De Bruin ML, Sparidans J, van't Veer MB, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol. 2009;27:4239–46.
5. Hess SL, Johannsdottir IM, Hamre H, et al. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol 2011.
6. Knobel H, Loge J, Brit Lund M, et al. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol. 2001;19:3226–33.
7. Ng AK, LaCasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol. 2011;29:1885–92.
8. Ruiz-Soto R, Sergent G, Gisselbrecht C, et al. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients. Cancer. 2005;104:2735–42.
9. Seshadri T, Pintilie M, Kuruvilla J, et al. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50:380–6.
10. van den Belt-Dusebout AW, Aleman BM, Besseling G, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys. 2009;75:1420–9.
11. Bellizzi KM, Rowland JH, Arora NK, et al. Physical activity and quality of life in adult survivors of non-Hodgkin's lymphoma. J Clin Oncol. 2009;27:960–6.
12. Doorduijn J, Buijt I, Holt B, et al. Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy. Eur J Haematol. 2005;75:116–23.
13. Hjermstad MJ, Fossa SD, Oldervoll L, et al. Fatigue in long-term Hodgkin's Disease survivors: a follow-up study. J Clin Oncol. 2005;23:6587–95.
14. Loge JH, Abrahamsen AF, Ekeberg O, et al. Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Br J Cancer. 1997;76:791–6.
15. Merli F, Bertini M, Luminari S, et al. Quality of life assessment in elderly patients with aggressive non-Hodgkin's lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi. Haematologica. 2004;89:973–8.
16. Mols F, Aaronson NK, Vingerhoets AJ, et al. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer. 2007;109:1659–67.
17. Oerlemans S, Mols F, Issa DE, et al. A high level of fatigue among (long-term) non-Hodgkin lymphoma survivors: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 2012.
18. Oerlemans S, Mols F, Nijziel MR, et al. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review. Ann Hematol. 2011;90:993–1004.
19. Pettengell R, Donatti C, Hoskin P, et al. The impact of follicular lymphoma on health-related quality of life. Ann Oncol. 2008;19:570–6.
20. Hjermstad MJ, Knobel H, Brinch L, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant. 2004;34:257–66.
21. Hjermstad MJ, Loge JH, Evensen SA, et al. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant. 1999;24:1219–28.
22. Wang Y, Zou L, Jiang M, et al. Measurement of distress in Chinese inpatients with lymphoma. Psychooncology 2012.
23. Thompson CA, Charlson ME, Schenkein E, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21:2262–6.
24. Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organisation; 2000.
25. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.
26. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986;292:344.
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
28. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
29. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–63.
30. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860–1.
31. van de Poll-Franse LV, Horevoorts N, Eenbergen MV, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 2011.
32. van de Poll-Franse LV, Mols F, Gundy CM, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 2011.
33. Hedeker DR, Gibbons RD. Longitudinal data analysis. Chapter 6. Hoboken, New Jersey: Wiley; 2006.
34. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. Chapter 7. Mahwah, NJ: Erlbaum; 2003.
35. Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29:89–96.
36. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–92.
37. Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care. 2001;39:1039–47.
38. van der Poel MWM, Oerlemans S, Schouten HC, et al. Quality of life more impaired in younger than in older diffuse large B-cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry Annals of Hematology 2013
39. Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22:761–72.
40. Oerlemans S, Husson O, Mols F, et al. Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors-results from a Dutch population-based study. Ann Hematol 2012.
41. Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv. 2013;7:484–92.